$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Oncology & Neur ... | Sell | S | 58.00 | 11,112 | 644,496 | 106,661 | 117.8 K to 106.7 K (-9.44 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Oncology & Neur ... | Buy | M | 47.49 | 21,112 | 1,002,609 | 117,773 | 96.7 K to 117.8 K (+21.84 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Grant | A | 0.00 | 1,975 | 0 | 18,679 | 16.7 K to 18.7 K (+11.82 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 1,975 | 0 | 17,201 | 15.2 K to 17.2 K (+12.97 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 1,975 | 0 | 18,201 | 16.2 K to 18.2 K (+12.17 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Grant | A | 0.00 | 1,975 | 0 | 11,977 | 10 K to 12 K (+19.75 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Grant | A | 0.00 | 1,975 | 0 | 11,977 | 10 K to 12 K (+19.75 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Grant | A | 0.00 | 1,975 | 0 | 22,275 | 20.3 K to 22.3 K (+9.73 %) |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | A | 57.67 | 6,111 | 352,421 | 6,111 | |
| May 19 2011 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Grant | A | 0.00 | 1,975 | 0 | 12,477 | 10.5 K to 12.5 K (+18.81 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 57.60 | 1,173 | 67,565 | 35,852 | 37 K to 35.9 K (-3.17 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.06 | 100,000 | 805,680 | 53,643,121 | 53.5 M to 53.6 M (+0.19 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.00 | 328,078 | 2,624,624 | 53,543,121 | 53.2 M to 53.5 M (+0.62 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Option Exercise | M | 47.49 | 40,555 | 1,925,957 | 21,112 | |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | S | 57.74 | 1,810 | 104,509 | 2,850 | 4.7 K to 2.9 K (-38.84 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | S | 57.60 | 10,000 | 576,000 | 96,661 | 106.7 K to 96.7 K (-9.38 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | S | 57.50 | 10,000 | 575,000 | 106,582 | 116.6 K to 106.6 K (-8.58 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | S | 57.25 | 20,555 | 1,176,774 | 116,582 | 137.1 K to 116.6 K (-14.99 %) |
| May 16 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Buy | M | 47.49 | 40,555 | 1,925,957 | 137,137 | 96.6 K to 137.1 K (+41.99 %) |
| May 13 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Sell | S | 57.00 | 10,000 | 570,000 | 47,109 | 57.1 K to 47.1 K (-17.51 %) |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 48.74 | 2,500 | 121,850 | 37,500 | |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 35.53 | 1,650 | 58,629 | 24,750 | |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 56.47 | 2,500 | 141,187 | 139,652 | 142.2 K to 139.7 K (-1.76 %) |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 48.74 | 2,500 | 121,850 | 142,141 | 139.6 K to 142.1 K (+1.79 %) |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 56.44 | 1,650 | 93,127 | 139,641 | 141.3 K to 139.6 K (-1.17 %) |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 35.53 | 1,650 | 58,629 | 141,291 | 139.6 K to 141.3 K (+1.18 %) |
| May 12 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.00 | 1,424,964 | 11,399,712 | 53,215,043 | 51.8 M to 53.2 M (+2.75 %) |
| May 10 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.00 | 67,345 | 538,760 | 51,790,079 | 51.7 M to 51.8 M (+0.13 %) |
| May 10 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.00 | 788,756 | 6,310,048 | 51,722,734 | 50.9 M to 51.7 M (+1.55 %) |
| May 06 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.00 | 2,578,022 | 20,624,176 | 50,933,978 | 48.4 M to 50.9 M (+5.33 %) |
| May 06 2011 | DGX | QUEST DIAGNOSTICS ... | QUEST DIAGNOSTICS INC | 10% Owner | Buy | P | 8.00 | 2,393,590 | 19,148,720 | 48,355,956 | 46 M to 48.4 M (+5.21 %) |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Option Exercise | M | 48.74 | 20,555 | 1,001,851 | 185,001 | |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Sell | S | 56.68 | 20,555 | 1,165,144 | 357,072 | 377.6 K to 357.1 K (-5.44 %) |
| May 04 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Buy | M | 48.74 | 20,555 | 1,001,851 | 377,437 | 356.9 K to 377.4 K (+5.76 %) |
| Apr 25 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 48.74 | 2,500 | 121,850 | 40,000 | |
| Apr 25 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 35.53 | 1,650 | 58,629 | 26,400 | |
| Apr 25 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 58.29 | 2,500 | 145,721 | 139,641 | 142.1 K to 139.6 K (-1.76 %) |
| Apr 25 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 48.74 | 2,500 | 121,850 | 142,141 | 139.6 K to 142.1 K (+1.79 %) |
| Apr 25 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 58.27 | 1,650 | 96,149 | 139,641 | 141.3 K to 139.6 K (-1.17 %) |
| Apr 25 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 35.53 | 1,650 | 58,629 | 141,291 | 139.6 K to 141.3 K (+1.18 %) |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Option Exercise | M | 48.74 | 20,555 | 1,001,851 | 205,556 | |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Sell | S | 57.70 | 20,555 | 1,185,987 | 356,882 | 377.4 K to 356.9 K (-5.45 %) |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Buy | M | 48.74 | 20,555 | 1,001,851 | 377,437 | 356.9 K to 377.4 K (+5.76 %) |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 48.74 | 2,500 | 121,850 | 42,500 | |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 35.53 | 1,650 | 58,629 | 28,050 | |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 57.77 | 2,500 | 144,428 | 139,641 | 142.1 K to 139.6 K (-1.76 %) |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 48.74 | 2,500 | 121,850 | 142,141 | 139.6 K to 142.1 K (+1.79 %) |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 57.80 | 1,650 | 95,365 | 139,641 | 141.3 K to 139.6 K (-1.17 %) |
| Apr 05 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 35.53 | 1,650 | 58,629 | 141,291 | 139.6 K to 141.3 K (+1.18 %) |
| Mar 23 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 35.53 | 1,650 | 58,629 | 29,700 | |
| Mar 23 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 48.74 | 2,500 | 121,850 | 45,000 | |
| Mar 23 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 54.18 | 1,650 | 89,400 | 139,641 | 141.3 K to 139.6 K (-1.17 %) |
| Mar 23 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 35.53 | 1,650 | 58,629 | 141,291 | 139.6 K to 141.3 K (+1.18 %) |
| Mar 23 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 54.20 | 2,500 | 135,511 | 139,641 | 142.1 K to 139.6 K (-1.76 %) |
| Mar 23 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 48.74 | 2,500 | 121,850 | 142,141 | 139.6 K to 142.1 K (+1.79 %) |
| Mar 11 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.50 | 2,596 | 149,266 | 41,058 | 43.7 K to 41.1 K (-5.95 %) |
| Mar 08 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | D | 56.51 | 2,243 | 126,741 | 43,654 | 45.9 K to 43.7 K (-4.89 %) |
| Mar 08 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | D | 56.51 | 4,611 | 260,545 | 139,641 | 144.3 K to 139.6 K (-3.20 %) |
| Mar 08 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Sell | D | 56.51 | 2,194 | 123,972 | 56,960 | 59.2 K to 57 K (-3.71 %) |
| Mar 08 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Sell | D | 56.51 | 11,090 | 626,640 | 356,882 | 368 K to 356.9 K (-3.01 %) |
| Mar 08 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | D | 56.51 | 2,742 | 154,937 | 96,582 | 99.3 K to 96.6 K (-2.76 %) |
| Feb 22 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.46 | 8,685 | 499,045 | 45,888 | 54.6 K to 45.9 K (-15.91 %) |
| Mar 08 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | D | 56.51 | 748 | 42,266 | 16,457 | 17.2 K to 16.5 K (-4.35 %) |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 35.53 | 1,650 | 58,629 | 31,350 | |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 48.74 | 2,500 | 121,850 | 47,500 | |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 56.79 | 1,650 | 93,699 | 144,252 | 145.9 K to 144.3 K (-1.13 %) |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 35.53 | 1,650 | 58,629 | 145,902 | 144.3 K to 145.9 K (+1.14 %) |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 56.75 | 2,500 | 141,883 | 144,252 | 146.8 K to 144.3 K (-1.70 %) |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 48.74 | 2,500 | 121,850 | 146,752 | 144.3 K to 146.8 K (+1.73 %) |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Option Exercise | M | 48.74 | 20,555 | 1,001,851 | 226,111 | |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Sell | S | 56.75 | 20,555 | 1,166,535 | 367,972 | 388.5 K to 368 K (-5.29 %) |
| Mar 03 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Buy | M | 48.74 | 20,555 | 1,001,851 | 388,527 | 368 K to 388.5 K (+5.59 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Option Exercise | A | 57.12 | 140,917 | 8,048,474 | 140,917 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Grant | A | 0.00 | 45,457 | 0 | 367,972 | 322.5 K to 368 K (+14.09 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Sell | D | 56.82 | 31,272 | 1,776,875 | 322,153 | 353.4 K to 322.2 K (-8.85 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Grant | A | 0.00 | 67,469 | 0 | 353,425 | 286 K to 353.4 K (+23.59 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 56.82 | 28,500 | 1,619,370 | 28,500 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 9,194 | 0 | 54,573 | 45.4 K to 54.6 K (+20.26 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | D | 56.82 | 4,961 | 281,884 | 45,379 | 50.3 K to 45.4 K (-9.85 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 13,646 | 0 | 50,340 | 36.7 K to 50.3 K (+37.19 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Option Exercise | A | 56.82 | 28,500 | 1,619,370 | 28,500 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Grant | A | 0.00 | 9,194 | 0 | 59,112 | 49.9 K to 59.1 K (+18.42 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Sell | D | 56.82 | 4,851 | 275,634 | 49,846 | 54.7 K to 49.8 K (-8.87 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Grant | A | 0.00 | 13,343 | 0 | 54,697 | 41.4 K to 54.7 K (+32.27 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | A | 56.82 | 9,500 | 539,790 | 9,500 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Grant | A | 0.00 | 3,065 | 0 | 17,174 | 14.1 K to 17.2 K (+21.72 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | D | 56.82 | 1,654 | 93,980 | 14,081 | 15.7 K to 14.1 K (-10.51 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Grant | A | 0.00 | 4,549 | 0 | 15,735 | 11.2 K to 15.7 K (+40.67 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Option Exercise | A | 56.82 | 38,000 | 2,159,160 | 38,000 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Grant | A | 0.00 | 12,259 | 0 | 36,726 | 24.5 K to 36.7 K (+50.10 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | A | 56.82 | 58,584 | 3,328,743 | 58,584 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Grant | A | 0.00 | 18,898 | 0 | 144,252 | 125.4 K to 144.3 K (+15.08 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | D | 56.82 | 13,002 | 738,774 | 125,354 | 138.4 K to 125.4 K (-9.40 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Grant | A | 0.00 | 28,050 | 0 | 138,356 | 110.3 K to 138.4 K (+25.43 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 57.15 | 294 | 16,802 | 11,186 | 11.5 K to 11.2 K (-2.56 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 57.28 | 293 | 16,783 | 11,480 | 11.8 K to 11.5 K (-2.49 %) |
| Feb 16 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.17 | 1,540 | 88,042 | 36,694 | 38.2 K to 36.7 K (-4.03 %) |
| Feb 16 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.19 | 18,457 | 1,055,556 | 38,153 | 56.6 K to 38.2 K (-32.60 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Option Exercise | M | 48.74 | 26,666 | 1,299,701 | 0 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Option Exercise | A | 56.82 | 38,000 | 2,159,160 | 38,000 | |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | S | 57.40 | 26,666 | 1,530,628 | 99,304 | 126 K to 99.3 K (-21.17 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Buy | M | 48.74 | 26,666 | 1,299,701 | 125,899 | 99.2 K to 125.9 K (+26.87 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Grant | A | 0.00 | 12,259 | 0 | 99,233 | 87 K to 99.2 K (+14.10 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Sell | D | 56.82 | 6,063 | 344,500 | 86,974 | 93 K to 87 K (-6.52 %) |
| Feb 17 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Grant | A | 0.00 | 16,678 | 0 | 93,037 | 76.4 K to 93 K (+21.84 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Payment of Exercise | F | 57.15 | 880 | 50,292 | 41,354 | 42.2 K to 41.4 K (-2.08 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | Simmons Wayne R. | Vice President, Ope ... | Payment of Exercise | F | 57.28 | 918 | 52,583 | 41,664 | 42.6 K to 41.7 K (-2.16 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.17 | 1,503 | 85,922 | 56,610 | 58.1 K to 56.6 K (-2.59 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 57.15 | 880 | 50,292 | 57,986 | 58.9 K to 58 K (-1.49 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 57.28 | 916 | 52,468 | 58,886 | 59.8 K to 58.9 K (-1.53 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Payment of Exercise | F | 57.15 | 5,545 | 316,897 | 285,956 | 291.5 K to 286 K (-1.90 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Payment of Exercise | F | 57.28 | 5,545 | 317,618 | 291,501 | 297 K to 291.5 K (-1.87 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Payment of Exercise | F | 57.15 | 1,075 | 61,436 | 76,359 | 77.4 K to 76.4 K (-1.39 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | Miller Joan Elizabeth | SVP-Pathology & Hos ... | Payment of Exercise | F | 57.28 | 1,207 | 69,137 | 77,043 | 78.3 K to 77 K (-1.54 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Payment of Exercise | F | 57.15 | 2,305 | 131,731 | 110,306 | 112.6 K to 110.3 K (-2.05 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Payment of Exercise | F | 57.28 | 2,305 | 132,030 | 112,611 | 114.9 K to 112.6 K (-2.01 %) |
| Feb 14 2011 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 57.28 | 1,201 | 68,793 | 24,455 | 25.7 K to 24.5 K (-4.68 %) |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | M | 42.63 | 20,000 | 852,500 | 0 | |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 57.56 | 30,000 | 1,726,881 | 10,002 | 40 K to 10 K (-75.00 %) |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Buy | M | 49.04 | 10,000 | 490,400 | 40,002 | 30 K to 40 K (+33.33 %) |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Buy | M | 42.63 | 20,000 | 852,500 | 30,002 | 10 K to 30 K (+199.96 %) |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Option Exercise | M | 35.53 | 152,000 | 5,400,940 | 0 | |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Sell | S | 57.53 | 152,000 | 8,745,122 | 297,046 | 449 K to 297 K (-33.85 %) |
| Feb 10 2011 | DGX | QUEST DIAGNOSTICS ... | MOHAPATRA SURYA N | Chairman, President ... | Buy | M | 35.53 | 152,000 | 5,400,940 | 449,046 | 297 K to 449 K (+51.17 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 41.21 | 264 | 10,878 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 31.06 | 350 | 10,869 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 41.35 | 262 | 10,832 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 47.47 | 20,000 | 949,300 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 35.69 | 304 | 10,851 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 58.57 | 21,180 | 1,240,426 | 16,704 | 37.9 K to 16.7 K (-55.91 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 41.21 | 264 | 10,878 | 37,884 | 37.6 K to 37.9 K (+0.70 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 31.06 | 350 | 10,869 | 37,620 | 37.3 K to 37.6 K (+0.94 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 41.35 | 262 | 10,832 | 37,270 | 37 K to 37.3 K (+0.71 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 47.47 | 20,000 | 949,300 | 37,008 | 17 K to 37 K (+117.59 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 35.69 | 304 | 10,851 | 17,008 | 16.7 K to 17 K (+1.82 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 29.53 | 20,000 | 590,524 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 58.60 | 5,000 | 292,985 | 15,226 | 20.2 K to 15.2 K (-24.72 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 58.58 | 5,000 | 292,877 | 20,226 | 25.2 K to 20.2 K (-19.82 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 58.55 | 10,000 | 585,520 | 25,226 | 35.2 K to 25.2 K (-28.39 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 29.53 | 20,000 | 590,524 | 35,226 | 15.2 K to 35.2 K (+131.35 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 29.53 | 20,000 | 590,524 | 0 | |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 58.99 | 5,000 | 294,935 | 16,226 | 21.2 K to 16.2 K (-23.56 %) |
| Feb 09 2011 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 58.96 | 5,000 | 294,818 | 21,226 | 26.2 K to 21.2 K (-19.07 %) |